Editorial Comment on "Is Docetaxel Essential for Darolutamide-Based Metastatic Hormone-Sensitive Prostate Cancer Therapy?". Hatano K. Int J Urol 2025 May 7. doi: 10.1111/iju.70093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hatano K. Editorial Comment on "Is Docetaxel Essential for Darolutamide-Based Metastatic Hormone-Sensitive Prostate Cancer Therapy?". Int J Urol 2025 May 7. doi: 10.1111/iju.70093.
PMID: 40329674